Cutaneous arteritis during olaparib treatment for ovarian cancer

被引：2
|
作者：
Iinuma, Shin [1 ]
Takahashi, Chiaki [1 ]
Negishi, Hideaki [2 ]
Ishida-Yamamoto, Akemi [3 ]
机构：
[1] Japanese Red Cross Kitami Hosp, Dept Dermatol, Kitami, Hokkaido, Japan
[2] Japanese Red Cross Kitami Hosp, Dept Obstet & Gynecol, Kitami, Hokkaido, Japan
[3] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan
来源：
JOURNAL OF DERMATOLOGY | 2021年 / 48卷 / 03期
关键词：
D O I：
10.1111/1346-8138.15749
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E140 / E141
页数：2
相关论文
共 50 条
  • [1] Olaparib for the treatment of ovarian cancer
    Lheureux, Stephanie
    Oza, Amit M.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (05): : 497 - 508
  • [2] Olaparib in the treatment of ovarian cancer
    Washington, Christina R.
    Richardson, Debra L.
    Moore, Kathleen N.
    FUTURE ONCOLOGY, 2019, 15 (30) : 3435 - 3449
  • [3] OLAPARIB FOR THE TREATMENT OF OVARIAN CANCER
    Bornstein, E.
    Jimeno, A.
    DRUGS OF TODAY, 2016, 52 (01) : 17 - 28
  • [4] Olaparib for the treatment of epithelial ovarian cancer
    McLachlan, Jennifer
    Banerjee, Susana
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 995 - 1003
  • [5] Profile of olaparib in the treatment of advanced ovarian cancer
    Chase, Dana M.
    Patel, Shreya
    Shields, Kristin
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2016, 8 : 125 - 129
  • [6] Olaparib-induced cutaneous vasculitis in a patient with recurrent ovarian cancer
    Maiko Fukui
    Ken Shiraishi
    Satoshi Yoshida
    Kazuki Yatsuzuka
    Takashi Matsumoto
    Koji Sayama
    European Journal of Dermatology, 2022, 32 : 655 - 656
  • [7] Olaparib-induced cutaneous vasculitis in a patient with recurrent ovarian cancer
    Fukui, Maiko
    Shiraishi, Ken
    Yoshida, Satoshi
    Yatsuzuka, Kazuki
    Matsumoto, Takashi
    Sayama, Koji
    EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (05) : 655 - 656
  • [8] Olaparib-induced cutaneous side effects in a patient with recurrent ovarian cancer
    Gou, Rei
    Horikawa, Naoki
    Kosaka, Kenzo
    BMJ CASE REPORTS, 2022, 15 (04)
  • [9] Analysis of glycemia during olaparib therapy in patients with ovarian cancer
    Stanislawiak-Rudowicz, Joanna
    Szalek, Edyta
    Czyrski, Andrzej
    Grzeskowiak, Edmund
    Madry, Radoslaw
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Olaparib for the treatment of BRCA-mutated advanced ovarian cancer
    Munroe, Marklie
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (14) : 1037 - 1041
12345